Article
Correlation of epidermal growth factor receptor mutation status and PD-L1 expression with [18F]FDG PET using volume-based parameters in non-small cell lung cancer.
Nuclear medicine communications - 1 Mar 2022
Ishimura Mariko, Norikane Takashi, Mitamura Katsuya, Yamamoto Yuka, Arai-Okuda Hanae, Murota Makiko, Ibuki Emi, Kanaji Nobuhiro, Nishiyama Yoshihiro
Abstract excerpt
OBJECTIVE: We investigated the relationship between 2-deoxy-2-[18F]fluoro-D-glucose (FDG) PET using volume-based parameters and epidermal growth factor receptor (EGFR) mutation status, programmed death-ligand-1 (PD-L1) expression level, and their combination, in pretreated non-small cell lung cancer (NSCLC). METHODS: FDG PET findings and EGFR mutation status and PD-L1 expression level were investigated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
